(4-fluoro-3-iodobenzyl)guanidine and Pheochromocytoma

(4-fluoro-3-iodobenzyl)guanidine has been researched along with Pheochromocytoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hanaoka, H; Higuchi, T; Tsushima, Y; Yamaguchi, A	1

Other Studies

1 other study(ies) available for (4-fluoro-3-iodobenzyl)guanidine and Pheochromocytoma

Article	Year
Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:5 Topics: Animals; Cell Line, Tumor; Female; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Iodobenzenes; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; PC12 Cells; Pheochromocytoma; Positron-Emission Tomography; Radioimmunotherapy; Radiopharmaceuticals; Rats; Treatment Outcome	2018

Article

Year

Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:5

Topics: Animals; Cell Line, Tumor; Female; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Iodobenzenes; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; PC12 Cells; Pheochromocytoma; Positron-Emission Tomography; Radioimmunotherapy; Radiopharmaceuticals; Rats; Treatment Outcome

2018